Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
3080 McCann Farm Drive , Garnet Valley, PA, 19060, US
Vanessa Zann and Andrew Parker share insights on poorly soluble APIs, approaches for modified release formulation development, and navigating accelerated approval pathways.
Released By Quotient Sciences
Pharmaceutics and Biopharmaceutics Considerations - Now Available to Watch On Demand
Challenges and Considerations for Achieving Success
Download this white paper to discover the time savings and financial benefits for drug developers that use Translational Pharmaceutics®.
The partnership combines Quotient's specialized early clinical and drug development capabilities with Lindus’ patient recruitment expertise and later-stage trial delivery.
By: Charlie Sternberg
Will combine Quotient Sciences’ expertise in early clinical development with Biorasi’s global patient recruitment capabilities.
Quotient Sciences gains access to Intrepid’s machine learning model, ANDROMEDA, an AI platform designed to develop and optimize clinical performance of drug products.
Mark previously served as CEO of Quotient Sciences.
By: Kristin Brooks
Will combine Quotient Sciences’ Translational Pharmaceutics platform with CPI’s expertise in small scale manufacture of RNA and LNP encapsulation.
BiaB is a modular, integrated, and automated RNA-micro factory designed to enable the end-to-end production of various RNA-based products.
MMV371 is being developed as a single-dose intramuscular injection that could provide up to three months of protection against malaria.
Quotient Sciences' chief executive talks about how the CDMO is positioning itself to stay ahead of the curve.
By: Tim Wright
The first human subjects have been dosed at Quotient Sciences' Nottingham, UK clinic.
Names Dr. Andrew Lewis as Chief Scientific Officer, Kieron Hall as Chief Marketing Officer, and Eric Bironneau as Chief Business Officer.
Increases current capacity of the Annex 1 compliant facility to meet increasing industry demand for fully integrated drug development programs.
Thierry succeeds Mark Egerton who is retiring after 18 as CEO.
By: Anthony Vecchione
For the validation of three bioequivalence studies supporting licensing applications with the FDA.
Quotient Sciences’ modified release capabilities enhance performance of EVX-101.
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
